Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

How to Manage (Treat) Immediate-type Adverse Reactions to GBCA

How to Manage (Treat) Immediate-type Adverse Reactions to GBCA AbstractAcute nonrenal adverse reactions to gadolinium-based contrast agents are infrequent and occur often unexpectedly. Most reactions are self-limiting and do not require treatment. The remaining adverse reactions are either moderate or severe and they require medical treatment. Prompt and effective treatment is very important and requires knowledge, training, and preparation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Topics in Magnetic Resonance Imaging Wolters Kluwer Health

How to Manage (Treat) Immediate-type Adverse Reactions to GBCA

Loading next page...
 
/lp/wolters-kluwer-health/how-to-manage-treat-immediate-type-adverse-reactions-to-gbca-VThTK1VP3M

References (44)

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
0899-3459
eISSN
1536-1004
DOI
10.1097/RMR.0000000000000107
pmid
27849654
Publisher site
See Article on Publisher Site

Abstract

AbstractAcute nonrenal adverse reactions to gadolinium-based contrast agents are infrequent and occur often unexpectedly. Most reactions are self-limiting and do not require treatment. The remaining adverse reactions are either moderate or severe and they require medical treatment. Prompt and effective treatment is very important and requires knowledge, training, and preparation.

Journal

Topics in Magnetic Resonance ImagingWolters Kluwer Health

Published: Dec 1, 2016

There are no references for this article.